In conclusion, our study showed that CXCL10 promotes tumor cell proliferation, invasion, and immune cell infiltration, implying its contribution in the progression of DCIS to invasive carcinoma of the breast. This evidence concerns the gene CXCL10 and ductal breast carcinoma in situ.